Release of our first CSR Report!
We’re excited to announce the publication of our first CSR Report!
Press releases
September 30, 2021
HTL launches a new bioproduction unit HTL4
Representing an investment of more than 50 million euros, this new unit dedicated to the bioproduction of pharmaceutical-grade hyaluronic acid represents a pivotal stage in the development of HTL and the largest investment ever made in the world for a biopolymer production unit.
It will enable HTL to become the largest producer of pharmaceutical-grade hyaluronic acid in the world and accelerate its international development.
Read more below.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Articles April 2, 2025François Fournier Featured in Korean Press
HTL Biotechnology CEO François Fournier spoke to leading Korean media DongA Ilbo, reaffirming Korea’s strategic importance and the strong, long-standing ties with Korean customers.
-
Articles March 28, 2025HTL Biotechnology at AMWC Monaco 2025
We are excited to share that HTL Biotechnology is present at the AMWC 2025 in Monaco.
-
Articles March 11, 2025HTL Biotechnology at CIBE China
On March 10 to 12, 2025, HTL Biotechnology was proud to be present at CIBE (China International Beauty Expo) in Guangzhou, reaffirming our commitment to the dermatology and beauty industries.